Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenchen Kenneth Wu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 21, 2005
Darbepoetin versus epoetinWenchen Kenneth Wu, Michael Montagne
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 5, 2003
Evaluation of outpatient adverse drug reactions leading to hospitalizationWenchen Kenneth Wu, Nicholas Pantaleo
Hepatology (Baltimore, Md.)|June 29, 2007
Is there a difference in the cost-effectiveness of erythropoietic therapies for the treatment of anemia in patients receiving HCV combination therapy?Wenchen Kenneth Wu, Mei Sheng Duh, Patrick Lefebvre
Research in Social & Administrative Pharmacy : RSAP|December 2, 2006
Use of health-related quality of life information in managed care formulary decision-makingWenchen Kenneth Wu, Robert B Sause, Christopher Zacker
American Journal of Pharmaceutical Education|April 3, 2018
Exploring the Community Pharmacist's Knowledge of Celiac DiseaseCarmela Avena-Woods, Robert A Mangione, Wenchen Kenneth Wu
Pharmacy (Basel, Switzerland)|August 3, 2019
Using the Theory of Planned Behavior to Understand Factors Influencing South Asian Consumers' Intention to Seek Pharmacist-Provided Medication Therapy Management ServicesShaquib Al Hasan, Jagannath Mohan Muzumdar, Rajesh Nayak, et al.
Clinical Drug Investigation|October 31, 2022
Cost-Utility Analysis Comparing Direct Oral Anticoagulant and Low Molecular Weight Heparin Therapies for Secondary Prevention of Cancer-Associated ThrombosisYoung Eun Shin, Arun Kumar, Monica Hwang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 21, 2005
Darbepoetin versus epoetinWenchen Kenneth Wu, Michael Montagne
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 5, 2003
Evaluation of outpatient adverse drug reactions leading to hospitalizationWenchen Kenneth Wu, Nicholas Pantaleo
Hepatology (Baltimore, Md.)|June 29, 2007
Is there a difference in the cost-effectiveness of erythropoietic therapies for the treatment of anemia in patients receiving HCV combination therapy?Wenchen Kenneth Wu, Mei Sheng Duh, Patrick Lefebvre
Research in Social & Administrative Pharmacy : RSAP|December 2, 2006
Use of health-related quality of life information in managed care formulary decision-makingWenchen Kenneth Wu, Robert B Sause, Christopher Zacker
American Journal of Pharmaceutical Education|April 3, 2018
Exploring the Community Pharmacist's Knowledge of Celiac DiseaseCarmela Avena-Woods, Robert A Mangione, Wenchen Kenneth Wu
Pharmacy (Basel, Switzerland)|August 3, 2019
Using the Theory of Planned Behavior to Understand Factors Influencing South Asian Consumers' Intention to Seek Pharmacist-Provided Medication Therapy Management ServicesShaquib Al Hasan, Jagannath Mohan Muzumdar, Rajesh Nayak, et al.
Clinical Drug Investigation|October 31, 2022
Cost-Utility Analysis Comparing Direct Oral Anticoagulant and Low Molecular Weight Heparin Therapies for Secondary Prevention of Cancer-Associated ThrombosisYoung Eun Shin, Arun Kumar, Monica Hwang, et al.
Pageof 1